Correlation Between Biofil Chemicals and Series Portfolios

Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and Series Portfolios at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and Series Portfolios into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and Series Portfolios Trust, you can compare the effects of market volatilities on Biofil Chemicals and Series Portfolios and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of Series Portfolios. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and Series Portfolios.

Diversification Opportunities for Biofil Chemicals and Series Portfolios

-0.4

Correlation Coefficient

Biofil Chemicals  Series Portfolios

Very good diversification

The 3 months correlation between Biofil and Series is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and Series Portfolios Trust in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Series Portfolios Trust and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with Series Portfolios. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Series Portfolios Trust has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and Series Portfolios go up and down completely randomly.

Pair Corralation between Biofil Chemicals and Series Portfolios

Assuming the 90 days trading horizon Biofil Chemicals Pharmaceuticals is expected to generate 3.06 times more return on investment than Series Portfolios. However, Biofil Chemicals is 3.06 times more volatile than Series Portfolios Trust. It trades about 0.04 of its potential returns per unit of risk. Series Portfolios Trust is currently generating about -0.08 per unit of risk. If you would invest  6,655  in Biofil Chemicals Pharmaceuticals on February 6, 2024 and sell it today you would earn a total of  100.00  from holding Biofil Chemicals Pharmaceuticals or generate 1.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	85.71%
Values	Daily Returns

Biofil Chemicals Pharmaceutica  vs.  Series Portfolios Trust

Biofil Chemicals Pha

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound forward indicators, Biofil Chemicals is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Series Portfolios Trust

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Series Portfolios Trust are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Series Portfolios may actually be approaching a critical reversion point that can send shares even higher in June 2024.

Pair Trading with Biofil Chemicals and Series Portfolios

The main advantage of trading using opposite Biofil Chemicals and Series Portfolios positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, Series Portfolios can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Series Portfolios will offset losses from the drop in Series Portfolios' long position.

The idea behind Biofil Chemicals Pharmaceuticals and Series Portfolios Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.